Citation:Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, et al 2002

Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up J Clin Oncol 2002 Dec 15;20(24):4665-72 [Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/12488411].

Critical appraisals

• Assign a critical appraisal

Citation	Assigned to	Status
Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, et al 2002	Michael.michael	completed
Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, et al 2002 2	Michael.michael	completed

Cited by

1. What is the optimal chemotherapy regimen and duration of therapy in extensive stage small cell lung cancer in the first line setting?